Skip to content
10-Q

Quarterly Report

Yew Bio-Pharm Group, Inc.

0001213900-19-015543

← back to feed
Filed
Aug 13, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Aug 13, 2019 51.7M sh
Short Term Debt Q2 2019 · Jun 30, 2019 $8.08M
Short Term Debt Q2 2019 · Dec 31, 2018 $5.76M
Current Liabilities Q2 2019 · Jun 30, 2019 $14.16M
Current Liabilities Q2 2019 · Dec 31, 2018 $7.06M
Total Liabilities Q2 2019 · Jun 30, 2019 $15.84M
Total Liabilities Q2 2019 · Dec 31, 2018 $8.61M
Current Assets Q2 2019 · Jun 30, 2019 $17.67M
Current Assets Q2 2019 · Dec 31, 2018 $12.39M
Total Assets Q2 2019 · Jun 30, 2019 $58.51M
Total Assets Q2 2019 · Dec 31, 2018 $49.69M
Stockholders Equity Q2 2019 · Mar 31, 2019 $42.49M
Stockholders Equity Q2 2019 · Jun 30, 2018 $47.16M
Stockholders Equity Q2 2019 · Mar 31, 2018 $46.88M
Stockholders Equity Q2 2019 · Dec 31, 2017 $45.17M
Shares Diluted Q2 2019 · Jun 30, 2018 55.87M sh
Shares Diluted Q2 2019 · Jun 30, 2018 55.5M sh
Operating Cash Flow Q2 2019 · Jun 30, 2018 $25.36M
Cash And Equivalents Q2 2019 · Jun 30, 2018 $772.77K
Cash And Equivalents Q2 2019 · Dec 31, 2017 $859.83K
Eps Diluted Q2 2019 · Jun 30, 2018 $0.03
Eps Diluted Q2 2019 · Jun 30, 2018 $0.03
Eps Basic Q2 2019 · Jun 30, 2018 $0.03
Eps Basic Q2 2019 · Jun 30, 2018 $0.03
Sga Expense Q2 2019 · Jun 30, 2018 $224.79K
Sga Expense Q2 2019 · Jun 30, 2018 $482.17K
Net Income Q2 2019 · Jun 30, 2018 $1.61M
Net Income Q2 2019 · Jun 30, 2018 $1.76M
Operating Income Q2 2019 · Jun 30, 2018 $2.07M
Operating Income Q2 2019 · Jun 30, 2018 $2.29M
Gross Profit Q2 2019 · Jun 30, 2018 $3.35M
Gross Profit Q2 2019 · Jun 30, 2018 $3.83M
Cost Of Revenue Q2 2019 · Jun 30, 2018 $11.47M
Cost Of Revenue Q2 2019 · Jun 30, 2018 $14.02M